Showing results (11-20 of 134) with videos related to
Sort By:
Pageof 14
Cancer Research|April 30, 2009
PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancersSusan Wee, Zainab Jagani, Kay Xiaoqin Xiang, et al.Current Gene Therapy|October 8, 2003
Non-traditional drug targets: high risk, high rewardTanya Sandrock, Alexander KambF1000Research|March 22, 2016
Publishing confirming and non-confirming dataBruce Alberts, Alexander KambCancer Biology & Therapy|September 26, 2003
New paradigms for cancer drug discoveryJason A Sager, Christoph LengauerCancer Biology & Therapy|September 26, 2003
New paradigms for cancer drug discoveryJason A Sager, Christoph LengauerF1000Research|January 14, 2021
Cancer T-cell therapy: building the foundation for a cureAlexander Kamb, William Y GoCancer Biology & Therapy|November 15, 2002
Exploring and exploiting instabilityLuís Teixeira da Costa, Christoph LengauerJournal of Biotechnology|August 2, 2003
Functional analysis of expressed peptides that bind yeast STE proteinsGiordano Caponigro, Majid Abedi, Alexander KambNature Reviews. Drug Discovery|May 3, 2005
Cancer drug discovery through collaborationChristoph Lengauer, Luis A Diaz, Saurabh SahaCell Cycle (Georgetown, Tex.)|January 30, 2009
Single-vector inducible lentiviral RNAi system for oncology target validationDmitri Wiederschain, Susan Wee, Lin Chen, et al.Pageof 14